The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Regulation of Cytokines, Cytokine Inhibitors, and Acute-Phase Proteins Following Anti-TNF-α Therapy in Rheumatoid Arthritis
Abstract
Treatment with a chimeric mAb to TNF-α has been shown to suppress inflammation and improve patient well-being in rheumatoid arthritis (RA), but the mechanisms of action of such treatment have not been fully explored. Here we show that in vivo administration of anti-TNF-α Ab, using a longitudinal analysis, results in the rapid down-regulation of a spectrum of cytokines, cytokine inhibitors, and acute-phase proteins. Marked diurnal variation in the serum levels of some of these were detected. These results were consistent with the concept of a cytokine-dependent cytokine cascade, and the degree of clinical benefit noted after anti-TNF-α therapy is probably due to the reduction in many proinflammatory mediators apart from TNF-α, such as IL-6, which reached normal levels within 24 h. Serum levels of cytokine inhibitors such as soluble p75 and p55 TNFR were reduced as was IL-1 receptor antagonist. Reductions in acute-phase proteins occurred after serum IL-6 fell and included serum amyloid A, haptoglobin, and fibrinogen. The latter reduction could be of importance, as it is a risk factor for atherosclerosis, which is augmented in RA patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,899
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,514
Self-citationThe Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., & Maseri, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310701 · Cited by 2,357
Impaired immune and acute-phase responses in interleukin-6-deficient mice
Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G. (1994) · Nature · doi:10.1038/368339a0 · Cited by 1,768
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Self-citationTransgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,660
Gauldie, J., Richards, C., Harnish, D., Lansdorp, P., & Baumann, H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7251 · Cited by 1,635
BRENNAN, F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90430-3 · Cited by 1,129
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
van Dullemen, H. M., van Deventer, S. J. H., Hommes, D. W., Bijl, H. A., Jansen, J., Tytgat, G. N. J., & Woody, J. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90277-5 · Cited by 1,084
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
Elliott, M. J., Maini, R. N., Feldmann, M., Long‐Fox, A., Charles, P., Katsikis, P., Brennan, F. M., Walker, J., Bijl, H., Ghrayeb, J., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780361206 · Cited by 1,038
Self-citationAnti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
Williams, R. O., Feldmann, M., & Maini, R. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9784 · Cited by 989
Self-citationArend, W. P., & Dayer, J. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380202 · Cited by 891
Houssiau, F. A., Devogelaer, J., Damme, J. V., Deuxchaisnes, C. N. D., & Snick, J. V. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310614 · Cited by 847
Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis
Hirano, T., Matsuda, T., Turner, M., Miyasaka, N., Buchan, G., Tang, B., Sato, K., Shimi, M., Maid, R., Feldmann, M., et al. (1988) · European Journal of Immunology · doi:10.1002/eji.1830181122 · Cited by 784
Self-citationConstruction and initial characterization of a mouse-human chimeric anti-TNF antibody
Knight, D. M., Trinh, H., Le, J., Siegel, S., Shealy, D., McDonough, M., Scallon, B., Moore, M. A., Vilcek, J., Daddona, P., et al. (1993) · Molecular Immunology · doi:10.1016/0161-5890(93)90106-l · Cited by 703
Interleukin-1 Receptor Antagonist
Arend, W. P. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60535-0 · Cited by 671
Elliott, M. J., Maini, R. N., Feldmann, M., Long-Fox, A., Charles, P., Bijl, J. A., & Woody, J. N. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90632-7 · Cited by 640
Self-citationChu, C. Q., Field, M., Feldmann, M., & Maini, R. N. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340908 · Cited by 578
Self-citationSaxne, T., Palladino, M. A., Heinegãrd, D., Talal, N., & Wollheim, F. A. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310816 · Cited by 566
TNFα—A PIVOTAL ROLE IN RHEUMATOID ARTHRITIS?
BRENNAN, F. M., MAINI, R. N., & FELDMANN, M. (1992) · Rheumatology · doi:10.1093/rheumatology/31.5.293 · Cited by 386
Self-citationThorbecke, G. J., Shah, R., Leu, C. H., Kuruvilla, A. P., Hardison, A. M., & Palladino, M. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7375 · Cited by 360
Cope, A. P., Gibbons, D., Brennan, F. M., Feldmann, M., Aderka, D., Doherty, M., Jones, A. C., Engelmann, H., Wallach, D., & Maini, R. N. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780351008 · Cited by 337
Self-citationHaworth, C., Brennan, F. M., Chantry, D., Turner, M., Maini, R. N., & Feldmann, M. (1991) · European Journal of Immunology · doi:10.1002/eji.1830211039 · Cited by 299
Self-citationWooley, P. H., Dutcher, J., Widmer, M. B., & Gillis, S. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.11.6602 · Cited by 293
CASTELL, J. V., GEIGER, T., GROSS, V., ANDUS, T., WALTER, E., HIRANO, T., KISHIMOTO, T., & HEINRICH, P. C. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb14383.x · Cited by 290
Brennan, F. M., Zachariae, C. O. C., Chantry, D., Larsen, C. G., Turner, M., Maini, R. N., Matsushima, K., & Feldmann, M. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200938 · Cited by 282
Self-citationAnti-Tumor Necrosis Factor-α Therapy of Rheumatoid Arthritis
Feldmann, M., Elliott, M. J., Maini, R. N., & Woody, J. N. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60891-3 · Cited by 230
Self-citationCHU, C. Q., FIELD, M., ALLARD, S., ABNEY, E., FELDMANN, M., & MAINI, R. N. (1992) · Rheumatology · doi:10.1093/rheumatology/31.10.653 · Cited by 229
Self-citationTetta, C., Camussi, G., Modena, V, Di Vittorio, C., & Baglioni, C. (1990) · Annals of the Rheumatic Diseases · doi:10.1136/ard.49.9.665 · Cited by 209
Circadian rhythm of serum interleukin-6 in rheumatoid arthritis.
Arvidson, N. G., Gudbjörnsson, B., Elfman, L., Rydén, A. C., Tötterman, T. H., & Hällgren, R. (1994) · Annals of the Rheumatic Diseases · doi:10.1136/ard.53.8.521 · Cited by 201
DELEURAN, B. W., CHU, C. Q., FIELD, M., BRENNAN, F. M., KATSIKIS, P., FELDMANN, M., & MAINI, R. N. (1992) · Rheumatology · doi:10.1093/rheumatology/31.12.801 · Cited by 183
Self-citationFirestein, G. S., & Zvaifler, N. J. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780300804 · Cited by 175
Probert, L., Plows, D., Kontogeorgos, G., & Kollias, G. A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250647 · Cited by 171
Lorenz, H., Antoni, C., Valerius, T., Repp, R., Grünke, M., Schwerdtner, N., Nüßlein, H. G., Woody, J. N., Kalden, J. R., & Manger, B. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.4.1646 · Cited by 160
Self-citationlnterleukin-6 (IL-6) in Synovial Fluid and Serum of Patients with Rheumatic Diseases
Swaak, A. J. G., Rooyen, A. V., Nieuwenhuis, E., & Aarden, L. A. (1988) · Scandinavian Journal of Rheumatology · doi:10.3109/03009748809098809 · Cited by 137
Synovial localization of tumor necrosis factor in patients with rheumatoid arthritis
Husby, G., & Williams, R. C. (1988) · Journal of Autoimmunity · doi:10.1016/0896-8411(88)90006-6 · Cited by 110
Paleolog, E. M., Delasalle, S., Buurman, W. A., & Feldmann, M. (1994) · Blood · doi:10.1182/blood.v84.8.2578.2578 · Cited by 109
Self-citationLu, Z., Brochier, J., Wijdenes, J., Brailly, H., Bataille, R., & Klein, B. (1992) · European Journal of Immunology · doi:10.1002/eji.1830221110 · Cited by 102
Fibrinogen in Ischaemic Heart Disease
Meade, T. W. (1995) · European Heart Journal · doi:10.1093/eurheartj/16.suppl_a.31 · Cited by 56
Husby, G. (1992) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(92)90001-t · Cited by 54
Goto, M., Fujisawa, M., Yamada, A., et al. (1990) · Annals of the Rheumatic Diseases · doi:10.1136/ard.49.3.172 · Cited by 51
The megakaryocyte platelet system and vascular disease
Brown, A. S., & Martin, J. F. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb02419.x · Cited by 50
van der Poll, T., van Deventer, S. J. H., Cate, H. T., Levi, M. M., & ten Cate, J. W. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.3.665 · Cited by 33
Cited by
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Lipsky, P. E., van der Heijde, D. M. F. M., St. Clair, E. W., Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Weisman, M., Emery, P., Feldmann, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432202 · Cited by 2,996
Self-citationTumour necrosis factor and cancer
Balkwill, F. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2628 · Cited by 1,915
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.001 · Cited by 1,628
Pathogenetic insights from the treatment of rheumatoid arthritis
McInnes, I. B., & Schett, G. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31472-1 · Cited by 1,345
Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
Feldmann, M., & Maini, R. N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.163 · Cited by 1,257
Self-citation
Metadata
- Authors
- Charles, P., Elliott, M. J., Davis, D., Potter, A., Kalden, J. R., Antoni, C., Breedveld, F. C., Smolen, J. S., Eberl, G., deWoody, K., Feldmann, M., & Maini, R. N.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-08-01
- Volume
- 163
- Issue
- 3
- Pages
- 1521-1528
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W4313347683
- Cited by
- 436
- References
- 44
- FWCI
- 9.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.